Sanofi India Limited — Others, 31-07-2025: Appointment

Sanofi India's board has approved the financial results for the quarter and half-year ended June 30, 2025. Revenue from operations for the quarter reached ₹406.3 Cr, with profit after tax at ₹69.5 Cr. For the half-year, revenue was ₹942.2 Cr and profit after tax stood at ₹189.0 Cr. The company also announced Ms. Renee Amonkar's retirement as Whole-time Director and Site Director - Goa. Mr. Mahadev Gawade, with over 20 years of pharma logistics and manufacturing experience, has been appointed as her successor in both roles, effective August 11, 2025, ensuring operational leadership continuity.